Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (2)

Search Criteria

  1. Client, organization or corporation number: 234102
Share this search Create an alert
Start over
Modify criteria

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (25)
Results: 1-25 | Export
  1. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 25 of 25 (2024-06-01 to present)
    Posted: 2024-06-11
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  2. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 23 of 25 (2024-05-14 to 2024-05-14)
    Posted: 2024-05-15
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  3. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 24 of 25 (2024-05-14 to 2024-06-01)
    Posted: 2024-05-15
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  4. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 21 of 25 (2023-06-19 to 2023-06-19)
    Posted: 2023-06-21
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  5. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 22 of 25 (2023-06-19 to 2024-05-14)
    Posted: 2023-07-10
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 5
  6. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 20 of 25 (2023-06-01 to 2023-06-19)
    Posted: 2023-06-15
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  7. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 19 of 25 (2023-03-13 to 2023-06-01)
    Posted: 2023-03-14
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  8. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: Martin Arès, Chief Executive Officer
    Registration: 18 of 25 (2023-01-03 to 2023-03-13)
    Posted: 2023-01-16
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  9. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 17 of 25 (2022-04-19 to 2023-01-03)
    Posted: 2022-04-19
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  10. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 16 of 25 (2021-11-08 to 2022-04-19)
    Posted: 2021-11-08
    Subject matter details: 7
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  11. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 15 of 25 (2021-04-30 to 2021-11-08)
    Posted: 2021-04-30
    Subject matter details: 6
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  12. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 13 of 25 (2021-01-20 to 2021-01-20)
    Posted: 2021-01-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  13. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 12 of 25 (2021-01-20 to 2021-01-20)
    Posted: 2021-01-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  14. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 14 of 25 (2021-01-20 to 2021-04-30)
    Posted: 2021-03-12
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  15. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 11 of 25 (2020-10-16 to 2021-01-20)
    Posted: 2020-10-19
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  16. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 10 of 25 (2019-04-04 to 2020-01-16)
    Posted: 2019-05-03
    Subject matter details: 4
    Government institutions: 4
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  17. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 9 of 25 (2014-06-16 to 2014-12-02)
    Posted: 2014-06-17
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  18. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 8 of 25 (2014-02-27 to 2014-06-16)
    Posted: 2014-03-14
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  19. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 7 of 25 (2013-05-27 to 2014-02-27)
    Posted: 2013-05-27
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  20. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 6 of 25 (2012-07-16 to 2013-05-27)
    Posted: 2012-07-16
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  21. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 5 of 25 (2012-03-23 to 2012-07-16)
    Posted: 2012-03-23
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  22. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 4 of 25 (2012-03-23 to 2012-03-23)
    Posted: 2012-03-23
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  23. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 3 of 25 (2011-09-02 to 2012-03-23)
    Posted: 2011-11-09
    Subject matter details: 11
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  24. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 2 of 25 (2010-10-18 to 2011-05-02)
    Posted: 2010-11-09
    Subject matter details: 10
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  25. Pharmascience Inc.
    Type: In-house Corporation
    Responsible officer: David Goodman, Chief Executive Officer
    Registration: 1 of 25 (2009-02-02 to 2009-09-03)
    Posted: 2009-04-03
    Subject matter details: 10
    Government institutions: 14
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
Date Modified: